chr11-118470934-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001197104.2(KMT2A):​c.503-728T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0615 in 152,262 control chromosomes in the GnomAD database, including 330 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.061 ( 330 hom., cov: 33)

Consequence

KMT2A
NM_001197104.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.752

Publications

6 publications found
Variant links:
Genes affected
KMT2A (HGNC:7132): (lysine methyltransferase 2A) This gene encodes a transcriptional coactivator that plays an essential role in regulating gene expression during early development and hematopoiesis. The encoded protein contains multiple conserved functional domains. One of these domains, the SET domain, is responsible for its histone H3 lysine 4 (H3K4) methyltransferase activity which mediates chromatin modifications associated with epigenetic transcriptional activation. This protein is processed by the enzyme Taspase 1 into two fragments, MLL-C and MLL-N. These fragments reassociate and further assemble into different multiprotein complexes that regulate the transcription of specific target genes, including many of the HOX genes. Multiple chromosomal translocations involving this gene are the cause of certain acute lymphoid leukemias and acute myeloid leukemias. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2010]
KMT2A Gene-Disease associations (from GenCC):
  • Wiedemann-Steiner syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0764 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001197104.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KMT2A
NM_001197104.2
MANE Select
c.503-728T>C
intron
N/ANP_001184033.1Q03164-3
KMT2A
NM_001412597.1
c.602-728T>C
intron
N/ANP_001399526.1A0AA34QVI8
KMT2A
NM_005933.4
c.503-728T>C
intron
N/ANP_005924.2Q03164-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KMT2A
ENST00000534358.8
TSL:1 MANE Select
c.503-728T>C
intron
N/AENSP00000436786.2Q03164-3
KMT2A
ENST00000389506.10
TSL:1
c.503-728T>C
intron
N/AENSP00000374157.5Q03164-1
ENSG00000285827
ENST00000648261.1
c.-728-728T>C
intron
N/AENSP00000498126.1A0A3B3ITZ1

Frequencies

GnomAD3 genomes
AF:
0.0614
AC:
9343
AN:
152146
Hom.:
330
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0784
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0364
Gnomad ASJ
AF:
0.0487
Gnomad EAS
AF:
0.0316
Gnomad SAS
AF:
0.0663
Gnomad FIN
AF:
0.0815
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0573
Gnomad OTH
AF:
0.0511
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0615
AC:
9360
AN:
152262
Hom.:
330
Cov.:
33
AF XY:
0.0620
AC XY:
4615
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.0786
AC:
3268
AN:
41568
American (AMR)
AF:
0.0364
AC:
556
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0487
AC:
169
AN:
3470
East Asian (EAS)
AF:
0.0318
AC:
165
AN:
5184
South Asian (SAS)
AF:
0.0667
AC:
322
AN:
4824
European-Finnish (FIN)
AF:
0.0815
AC:
863
AN:
10594
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0573
AC:
3897
AN:
68010
Other (OTH)
AF:
0.0506
AC:
107
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
446
892
1337
1783
2229
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0600
Hom.:
431
Bravo
AF:
0.0598
Asia WGS
AF:
0.0470
AC:
163
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.041
DANN
Benign
0.62
PhyloP100
-0.75
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7948661; hg19: chr11-118341649; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.